卵巢腺癌肝转移的射频消融：病例报告及文献综述
Radiofrequency ablation of liver metastasis from ovarian adenocarcinoma: case report and literature review.
作者信息
Bojalian Michael O, Machado Gustavo R, Swensen Ron, Reeves Mark E
机构信息
Division of Surgical Oncology, Department of Surgery, Loma Linda University and VA Medical Centers, Loma Linda, CA 92350, USA.
出版信息
Gynecol Oncol. 2004 May;93(2):557-60. doi: 10.1016/j.ygyno.2004.01.041.
BACKGROUND
Radiofrequency ablation (RFA) is a minimally invasive technique that can eradicate malignant disease in the liver, including metastatic disease from gynecological primary tumors.
CASE
An 81-year-old female underwent percutaneous RFA for a solitary intrahepatic metastatic lesion that was her only known site of disease 2 years after definitive surgery and chemotherapy for stage IIIC ovarian adenocarcinoma. She was able to start systemic chemotherapy 1 week after RFA, and continues to be free of disease in the liver.
CONCLUSION
RFA can be a useful tool for treating liver tumors in patients who would otherwise not be candidates for liver resection. Its advantages include minimal invasiveness, low morbidity, and rapid recovery for expeditious treatment with systemic chemotherapy.
背景
射频消融术（RFA）是一种微创技术，能够根除肝脏中的恶性疾病，包括妇科原发性肿瘤的转移性疾病。
病例
一名81岁女性因孤立性肝内转移灶接受了经皮射频消融术，该转移灶是她在IIIC期卵巢腺癌接受根治性手术和化疗2年后唯一已知的疾病部位。她在射频消融术后1周能够开始全身化疗，肝脏持续无疾病。
结论
对于那些原本不适合肝切除的患者，射频消融术可成为治疗肝肿瘤的有用工具。其优点包括微创、低发病率以及能快速恢复以便迅速进行全身化疗。
Zotero 插件